Journal: Clinical and Developmental Immunology

Article Title: Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination and Field Investigation in Italian Cattle Population

doi: 10.1155/2008/584624

Figure Lengend Snippet: Number of sera from the National Serum Bank (NSB, collected during the 2001–2003 period) and tested with RB51-CFT, on regional basis.

Article Snippet: The RB51 vaccine was kindly provided by CZ Veterinaria (Pontevedra, Spain), the European distributor of the product, under license from the Colorado Serum Company (Denver, Colo, USA).

Techniques:

Journal: Clinical and Developmental Immunology

Article Title: Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination and Field Investigation in Italian Cattle Population

doi: 10.1155/2008/584624

Figure Lengend Snippet: Number of sera from the National Brucellosis Eradication Program (NBEP, collected during year 2004) and tested with RB51-CFT, on regional basis.

Article Snippet: The RB51 vaccine was kindly provided by CZ Veterinaria (Pontevedra, Spain), the European distributor of the product, under license from the Colorado Serum Company (Denver, Colo, USA).

Techniques:

Journal: Clinical and Developmental Immunology

Article Title: Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination and Field Investigation in Italian Cattle Population

doi: 10.1155/2008/584624

Figure Lengend Snippet: Median, maximum value, minimum value, 25th percentile, and 75th percentile of RB51-CFT results in vaccinated animals ( n = 10).

Article Snippet: The RB51 vaccine was kindly provided by CZ Veterinaria (Pontevedra, Spain), the European distributor of the product, under license from the Colorado Serum Company (Denver, Colo, USA).

Techniques:

Journal: Clinical and Developmental Immunology

Article Title: Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination and Field Investigation in Italian Cattle Population

doi: 10.1155/2008/584624

Figure Lengend Snippet: Median, maximum value, minimum value, 25th percentile, and 75th percentile of RB51-CFT results in control animals ( n = 5).

Article Snippet: The RB51 vaccine was kindly provided by CZ Veterinaria (Pontevedra, Spain), the European distributor of the product, under license from the Colorado Serum Company (Denver, Colo, USA).

Techniques: Control

Journal: Clinical and Developmental Immunology

Article Title: Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination and Field Investigation in Italian Cattle Population

doi: 10.1155/2008/584624

Figure Lengend Snippet: Percent vaccinated animals correctly identified by the RB51-CFT and 95% Credibility Intervals.

Article Snippet: The RB51 vaccine was kindly provided by CZ Veterinaria (Pontevedra, Spain), the European distributor of the product, under license from the Colorado Serum Company (Denver, Colo, USA).

Techniques:

Journal: Clinical and Developmental Immunology

Article Title: Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination and Field Investigation in Italian Cattle Population

doi: 10.1155/2008/584624

Figure Lengend Snippet: Percent control animals correctly identified by the RB51-CFT and 95% Credibility Intervals.

Article Snippet: The RB51 vaccine was kindly provided by CZ Veterinaria (Pontevedra, Spain), the European distributor of the product, under license from the Colorado Serum Company (Denver, Colo, USA).

Techniques: Control

Journal: Clinical and Developmental Immunology

Article Title: Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination and Field Investigation in Italian Cattle Population

doi: 10.1155/2008/584624

Figure Lengend Snippet: Percent of sera coming from the National Serum Bank (NSB, collected during the 2001–2003 period) and resulted positive to RB51-CFT, on regional basis.

Article Snippet: The RB51 vaccine was kindly provided by CZ Veterinaria (Pontevedra, Spain), the European distributor of the product, under license from the Colorado Serum Company (Denver, Colo, USA).

Techniques:

Journal: Clinical and Developmental Immunology

Article Title: Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination and Field Investigation in Italian Cattle Population

doi: 10.1155/2008/584624

Figure Lengend Snippet: Percent of sera coming from the National Brucellosis Eradication Plan (NBEP, collected during year 2004) and resulted positive to RB51-CFT, on regional basis.

Article Snippet: The RB51 vaccine was kindly provided by CZ Veterinaria (Pontevedra, Spain), the European distributor of the product, under license from the Colorado Serum Company (Denver, Colo, USA).

Techniques:

Journal: PLoS Neglected Tropical Diseases

Article Title: Beyond the ‘big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies

doi: 10.1371/journal.pntd.0007899

Figure Lengend Snippet: Binding efficacy determined using an end-point ELISA is depicted here. Optical density at 405 nm is plotted against various dilutions of antivenoms. The values are provided as mean absorbance of triplicates, and error bars represent standard deviation. The dotted lines represent antivenom titres, which were determined using purified IgG from unimmunized horses as negative control. Alphabets next to the dotted lines indicate the titre of the respective antivenom (P: Premium Serums & Vaccines Pvt. Ltd.; V: VINS Bioproducts Ltd.; B: Bharat Serums and Vaccines Ltd; and H: Haffkine Institute).

Article Snippet: Both Premium Serums and VINS antivenoms exhibited poor binding against West Bengal and Arunachal Pradesh populations of N . kaouthia (titre of 1:500), while Bharat Serums and Haffkine antivenoms exhibited significantly increased binding.

Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Standard Deviation, Purification, Negative Control, Vaccines

Journal: PLoS Neglected Tropical Diseases

Article Title: Beyond the ‘big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies

doi: 10.1371/journal.pntd.0007899

Figure Lengend Snippet: This figure depicts the results of western blotting experiments. Following the electrophoretic separation of snake venoms (25 μg) on a 4–20% gradient SDS-PAGE (A), bands were electroblotted onto nitrocellulose membranes, and incubated with 1:200 dilutions of various antivenoms: (B) Naïve IgG; (C) Premium Serums & Vaccines Pvt. Ltd.; (D) VINS Bioproducts Ltd.; (E) Bharat Serums; and (F) Haffkine Institute.

Article Snippet: Both Premium Serums and VINS antivenoms exhibited poor binding against West Bengal and Arunachal Pradesh populations of N . kaouthia (titre of 1:500), while Bharat Serums and Haffkine antivenoms exhibited significantly increased binding.

Techniques: Western Blot, SDS Page, Incubation, Vaccines

Journal: PLOS ONE

Article Title: Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia: A systematic review

doi: 10.1371/journal.pone.0288723

Figure Lengend Snippet: Neutralizing and cross-neutralizing abilities of available antivenoms against the lethality of medically important venomous snakes in Asia according to preclinical evidence.

Article Snippet: Moreover, the lethality of N . naja found in Sri Lanka can be neutralized by snake venom antiserum (polyvalent) from Bharat Serums and Vaccines Limited, India, and snake venom antiserum I.P. (Asia) from VINS Bioproducts Ltd., India with various degrees of effectiveness [ , , , ].

Techniques: Combined Bisulfite Restriction Analysis Assay